Skip to main content
Top
Published in: Current Urology Reports 11/2019

01-11-2019 | Pituitary Adenoma | Men’s Health (A Dabaja, Section Editor)

Pituitary Dysfunction Among Men Presenting with Hypogonadism

Authors: Shiri Levy, Mingxue Arguello, Mohamed Macki, Sudhaker D. Rao

Published in: Current Urology Reports | Issue 11/2019

Login to get access

Abstract

Purpose of Review

Hypogonadism is a common endocrine dysfunction. This review focuses on the most up-to-date guideline for evaluation of pituitary function among men presenting with signs and symptoms of hypogonadism.

Recent Findings

The clinician must differentiate between primary (testicular) and secondary (pituitary-hypothalamic or central) hypogonadisms and be aware of adult-onset hypogonadism. If gonadotropins are low or inappropriately normal, the clinician must consider potential reversible causes in the hypothalamus-pituitary axis. Also, it is critical to understand the pitfalls of testosterone testing. When clinically indicated, evaluation of other pituitary hormone functions as well as pituitary magnetic resonance imaging may be necessary. Furthermore, it is essential to recognize that pituitary incidentalomas are common. Patients with microprolactinoma are more likely to present with symptoms of sexual dysfunction while those with macroprolactinoma are more likely to present with symptoms of mass effect. Some functional pituitary tumors respond to drug therapy while other nonfunctional tumors require surgical intervention.

Summary

It is important for the clinician to understand the proper work-up of the hypogonadal patient with pituitary dysfunction and when necessary to refer to an endocrinologist or a neurosurgeon.
Literature
1.
go back to reference •• Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103:1715–44 Provides updated guidelines for testosterone therapy in hypogonadal men. Discusses how to make the diagnosis of hypogonadism and the appropriate testing required. The update discusses additional diagnostic evaluation in men found to be hypogonadal.CrossRef •• Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103:1715–44 Provides updated guidelines for testosterone therapy in hypogonadal men. Discusses how to make the diagnosis of hypogonadism and the appropriate testing required. The update discusses additional diagnostic evaluation in men found to be hypogonadal.CrossRef
2.
go back to reference • Mulhall JP, Trost LW, Brannigan RE, Kurtz EG, Redmon JB, Chiles KA, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200:423–32 Provides guidelines for testosterone therapy in hypogonadal men. Discusses how to make the diagnosis of hypogonadism and the testing required.CrossRef • Mulhall JP, Trost LW, Brannigan RE, Kurtz EG, Redmon JB, Chiles KA, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200:423–32 Provides guidelines for testosterone therapy in hypogonadal men. Discusses how to make the diagnosis of hypogonadism and the testing required.CrossRef
3.
go back to reference Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006;60:762–9.CrossRef Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006;60:762–9.CrossRef
4.
go back to reference Baskin HJ, Cobin RH, Duick DS, Gharib H, Guttler RB, Kaplan MM, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract. 2002;8:457–69.CrossRef Baskin HJ, Cobin RH, Duick DS, Gharib H, Guttler RB, Kaplan MM, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract. 2002;8:457–69.CrossRef
5.
go back to reference Tajar A, Forti G, O'Neill TW, Lee DM, Silman AJ, Finn JD, et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab. 2010;95:1810–8.CrossRef Tajar A, Forti G, O'Neill TW, Lee DM, Silman AJ, Finn JD, et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab. 2010;95:1810–8.CrossRef
6.
go back to reference •• Seftel AD. Re: adult-onset hypogonadism. J Urol. 2016;196:1722 Discusses adult-onset hypogonadism (AOH), which is a term applied to define middle-aged and older men with low total testosterone accompanied by low or normal gonadotropin levels and associated signs and symptoms of hypogonadism. These men likely have a component of both primary and secondary hypogonadisms. It is important to recognize this group of patients because they may be misdiagnosed as secondary hypogonadism, and further evaluation of such men may generate unnecessary health care costs and anxiety for the patients.PubMed •• Seftel AD. Re: adult-onset hypogonadism. J Urol. 2016;196:1722 Discusses adult-onset hypogonadism (AOH), which is a term applied to define middle-aged and older men with low total testosterone accompanied by low or normal gonadotropin levels and associated signs and symptoms of hypogonadism. These men likely have a component of both primary and secondary hypogonadisms. It is important to recognize this group of patients because they may be misdiagnosed as secondary hypogonadism, and further evaluation of such men may generate unnecessary health care costs and anxiety for the patients.PubMed
7.
go back to reference Serhal D, Weil RJ, Hamrahian AH. Evaluation and management of pituitary incidentalomas. Cleve Clin J Med. 2008;75:793–801.CrossRef Serhal D, Weil RJ, Hamrahian AH. Evaluation and management of pituitary incidentalomas. Cleve Clin J Med. 2008;75:793–801.CrossRef
8.
go back to reference Sanno N, Oyama K, Tahara S, Teramoto A, Kato Y. A survey of pituitary incidentaloma in Japan. Eur J Endocrinol. 2003;149:123–7.CrossRef Sanno N, Oyama K, Tahara S, Teramoto A, Kato Y. A survey of pituitary incidentaloma in Japan. Eur J Endocrinol. 2003;149:123–7.CrossRef
9.
go back to reference Freda PU, Beckers AM, Katznelson L, Molitch ME, Montori VM, Post KD, et al. Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:894–904.CrossRef Freda PU, Beckers AM, Katznelson L, Molitch ME, Montori VM, Post KD, et al. Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:894–904.CrossRef
10.
go back to reference Day PF, Guitelman M, Artese R, Fiszledjer L, Chervin A, Vitale NM, et al. Retrospective multicentric study of pituitary incidentalomas. Pituitary. 2004;7:145–8.CrossRef Day PF, Guitelman M, Artese R, Fiszledjer L, Chervin A, Vitale NM, et al. Retrospective multicentric study of pituitary incidentalomas. Pituitary. 2004;7:145–8.CrossRef
11.
go back to reference Dalvi M, Walker BR, Strachan MW, Zammitt NN, Gibb FW. The prevalence of structural pituitary abnormalities by MRI scanning in men presenting with isolated hypogonadotrophic hypogonadism. Clin Endocrinol. 2016;84:858–61.CrossRef Dalvi M, Walker BR, Strachan MW, Zammitt NN, Gibb FW. The prevalence of structural pituitary abnormalities by MRI scanning in men presenting with isolated hypogonadotrophic hypogonadism. Clin Endocrinol. 2016;84:858–61.CrossRef
12.
go back to reference Vargas G, Gonzalez B, Ramirez C, Ferreira A, Espinosa E, Mendoza V, et al. Clinical characteristics and treatment outcome of 485 patients with nonfunctioning pituitary macroadenomas. Int J Endocrinol. 2015;2015:756069.CrossRef Vargas G, Gonzalez B, Ramirez C, Ferreira A, Espinosa E, Mendoza V, et al. Clinical characteristics and treatment outcome of 485 patients with nonfunctioning pituitary macroadenomas. Int J Endocrinol. 2015;2015:756069.CrossRef
13.
go back to reference • Pinzone JJ, Katznelson L, Danila DC, Pauler DK, Miller CS, Klibanski A. Primary medical therapy of micro- and macroprolactinomas in men. J Clin Endocrinol Metab. 2000;85:3053–7 Investigated the clinical presentation and treatment outcome in men with prolactinomas. Results showed normalization of serum prolactin levels occurred in ~ 80% of men with prolactinomas.PubMed • Pinzone JJ, Katznelson L, Danila DC, Pauler DK, Miller CS, Klibanski A. Primary medical therapy of micro- and macroprolactinomas in men. J Clin Endocrinol Metab. 2000;85:3053–7 Investigated the clinical presentation and treatment outcome in men with prolactinomas. Results showed normalization of serum prolactin levels occurred in ~ 80% of men with prolactinomas.PubMed
14.
go back to reference Katznelson L, Kleinberg D, Vance ML, Stavrou S, Pulaski KJ, Schoenfeld DA, et al. Hypogonadism in patients with acromegaly: data from the multi-centre acromegaly registry pilot study. Clin Endocrinol. 2001;54:183–8.CrossRef Katznelson L, Kleinberg D, Vance ML, Stavrou S, Pulaski KJ, Schoenfeld DA, et al. Hypogonadism in patients with acromegaly: data from the multi-centre acromegaly registry pilot study. Clin Endocrinol. 2001;54:183–8.CrossRef
15.
go back to reference Acquati S, Pizzocaro A, Tomei G, Giovanelli M, Libe R, Faglia G, et al. A comparative evaluation of effectiveness of medical and surgical therapy in patients with macroprolactinoma. J Neurosurg Sci. 2001;45:65–9.PubMed Acquati S, Pizzocaro A, Tomei G, Giovanelli M, Libe R, Faglia G, et al. A comparative evaluation of effectiveness of medical and surgical therapy in patients with macroprolactinoma. J Neurosurg Sci. 2001;45:65–9.PubMed
16.
go back to reference Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD, et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol. 2006;65:265–73.CrossRef Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD, et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol. 2006;65:265–73.CrossRef
17.
go back to reference Nelson AT Jr, Tucker HS Jr, Becker DP. Residual anterior pituitary function following transsphenoidal resection of pituitary macroadenomas. J Neurosurg. 1984;61:577–80.CrossRef Nelson AT Jr, Tucker HS Jr, Becker DP. Residual anterior pituitary function following transsphenoidal resection of pituitary macroadenomas. J Neurosurg. 1984;61:577–80.CrossRef
18.
go back to reference Molitch ME, Elton RL, Blackwell RE, Caldwell B, Chang RJ, Jaffe R, et al. Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study. J Clin Endocrinol Metab. 1985;60:698–705.CrossRef Molitch ME, Elton RL, Blackwell RE, Caldwell B, Chang RJ, Jaffe R, et al. Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study. J Clin Endocrinol Metab. 1985;60:698–705.CrossRef
19.
go back to reference Colao A, Di Sarno A, Landi ML, Scavuzzo F, Cappabianca P, Pivonello R, et al. Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients. J Clin Endocrinol Metab. 2000;85:2247–52.PubMed Colao A, Di Sarno A, Landi ML, Scavuzzo F, Cappabianca P, Pivonello R, et al. Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients. J Clin Endocrinol Metab. 2000;85:2247–52.PubMed
20.
go back to reference Walsh JP, Pullan PT. Hyperprolactinaemia in males: a heterogeneous disorder. Aust NZ J Med. 1997;27:385–90.CrossRef Walsh JP, Pullan PT. Hyperprolactinaemia in males: a heterogeneous disorder. Aust NZ J Med. 1997;27:385–90.CrossRef
21.
go back to reference Jaffe RB. Editorial comment: recurrence of hyperprolactinemia after withdrawal of long-term cabergoline therapy. Obstet Gynecol Surv. 2010;65:28–9.CrossRef Jaffe RB. Editorial comment: recurrence of hyperprolactinemia after withdrawal of long-term cabergoline therapy. Obstet Gynecol Surv. 2010;65:28–9.CrossRef
22.
go back to reference Jacob M, Raverot G, Jouanneau E, Borson-Chazot F, Perrin G, Rabilloud M, et al. Predicting visual outcome after treatment of pituitary adenomas with optical coherence tomography. Am J Ophthalmol. 2009;147:64–70 e2.CrossRef Jacob M, Raverot G, Jouanneau E, Borson-Chazot F, Perrin G, Rabilloud M, et al. Predicting visual outcome after treatment of pituitary adenomas with optical coherence tomography. Am J Ophthalmol. 2009;147:64–70 e2.CrossRef
23.
go back to reference Robenshtok E, Benbassat CA, Hirsch D, Tzvetov G, Cohen ZR, Iraqi HM, et al. Clinical course and outcome of nonfunctioning pituitary adenomas in the elderly compared with younger age groups. Endocr Pract. 2014;20:159–64.CrossRef Robenshtok E, Benbassat CA, Hirsch D, Tzvetov G, Cohen ZR, Iraqi HM, et al. Clinical course and outcome of nonfunctioning pituitary adenomas in the elderly compared with younger age groups. Endocr Pract. 2014;20:159–64.CrossRef
24.
go back to reference Berkmann S, Fandino J, Muller B, Kothbauer KF, Henzen C, Landolt H. Pituitary surgery: experience from a large network in Central Switzerland. Swiss Med Wkly. 2012;142:w13680.PubMed Berkmann S, Fandino J, Muller B, Kothbauer KF, Henzen C, Landolt H. Pituitary surgery: experience from a large network in Central Switzerland. Swiss Med Wkly. 2012;142:w13680.PubMed
25.
go back to reference Halvorsen H, Ramm-Pettersen J, Josefsen R, Ronning P, Reinlie S, Meling T, et al. Surgical complications after transsphenoidal microscopic and endoscopic surgery for pituitary adenoma: a consecutive series of 506 procedures. Acta Neurochir. 2014;156:441–9.CrossRef Halvorsen H, Ramm-Pettersen J, Josefsen R, Ronning P, Reinlie S, Meling T, et al. Surgical complications after transsphenoidal microscopic and endoscopic surgery for pituitary adenoma: a consecutive series of 506 procedures. Acta Neurochir. 2014;156:441–9.CrossRef
26.
go back to reference Chen L, White WL, Spetzler RF, Xu B. A prospective study of nonfunctioning pituitary adenomas: presentation, management, and clinical outcome. J Neuro-Oncol. 2011;102:129–38.CrossRef Chen L, White WL, Spetzler RF, Xu B. A prospective study of nonfunctioning pituitary adenomas: presentation, management, and clinical outcome. J Neuro-Oncol. 2011;102:129–38.CrossRef
27.
go back to reference Comtois R, Beauregard H, Somma M, Serri O, Aris-Jilwan N, Hardy J. The clinical and endocrine outcome to trans-sphenoidal microsurgery of nonsecreting pituitary adenomas. Cancer. 1991;68:860–6.CrossRef Comtois R, Beauregard H, Somma M, Serri O, Aris-Jilwan N, Hardy J. The clinical and endocrine outcome to trans-sphenoidal microsurgery of nonsecreting pituitary adenomas. Cancer. 1991;68:860–6.CrossRef
28.
go back to reference Dallapiazza RF, Grober Y, Starke RM, Laws ER Jr, Jane JA Jr. Long-term results of endonasal endoscopic transsphenoidal resection of nonfunctioning pituitary macroadenomas. Neurosurgery. 2015;76:42–52 discussion -3.CrossRef Dallapiazza RF, Grober Y, Starke RM, Laws ER Jr, Jane JA Jr. Long-term results of endonasal endoscopic transsphenoidal resection of nonfunctioning pituitary macroadenomas. Neurosurgery. 2015;76:42–52 discussion -3.CrossRef
Metadata
Title
Pituitary Dysfunction Among Men Presenting with Hypogonadism
Authors
Shiri Levy
Mingxue Arguello
Mohamed Macki
Sudhaker D. Rao
Publication date
01-11-2019
Publisher
Springer US
Published in
Current Urology Reports / Issue 11/2019
Print ISSN: 1527-2737
Electronic ISSN: 1534-6285
DOI
https://doi.org/10.1007/s11934-019-0935-z

Other articles of this Issue 11/2019

Current Urology Reports 11/2019 Go to the issue

New Imaging Techniques (S Rais-Bahrami and K Porter, Section Editors)

Renal Cell Carcinoma: the Oncologist Asks, Can PSMA PET/CT Answer?

Lower Urinary Tract Symptoms & Voiding Dysfunction (J Sandhu, Section Editor)

Female Urethral Strictures: Review of Diagnosis, Etiology, and Management

Lower Urinary Tract Symptoms & Voiding Dysfunction (J Sandhu, Section Editor)

Management of Pelvic Organ Prolapse After Radical Cystectomy

Lower Urinary Tract Symptoms & Voiding Dysfunction (J Sandhu, Section Editor)

Management Strategies for Nocturia

New Imaging Techniques (S Rais-Bahrami and K Porter, Section Editors)

Advanced Imaging in Female Infertility

Lower Urinary Tract Symptoms & Voiding Dysfunction (J Sandhu, Section Editor)

Neobladder-Vaginal Fistula: Surgical Management Techniques